| Kenneth R Lander M.d. P.c. | |
|
30 Medical Center Blvd Suite 202 Chester PA 19013-3955 | |
| (610) 447-8840 | |
| (610) 447-8895 |
| Full Name | Kenneth R Lander M.d. P.c. |
|---|---|
| Speciality | Internal Medicine |
| Location | 30 Medical Center Blvd, Chester, Pennsylvania |
| Authorized Official Name and Position | Kenneth R Lander (CEO/PRESIDENT) |
| Authorized Official Contact | 6104478840 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth R Lander M.d. P.c. 30 Medical Center Blvd Suite 202 Chester PA 19013-3955 Ph: (610) 447-8840 | Kenneth R Lander M.d. P.c. 30 Medical Center Blvd Suite 202 Chester PA 19013-3955 Ph: (610) 447-8840 |
| NPI Number | 1144276114 |
|---|---|
| Provider Enumeration Date | 05/25/2006 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 8325000334 |
|---|---|
| Medicare Enrollment ID | O20041102000435 |
News Archive
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.
Adults who use pet therapy while recovering from total joint-replacement surgery require 50 percent less pain medication than those who do not. These findings were presented at the 18th Annual Conference of the International Society of Anthrozoology and the First Human Animal Interaction Conference (HAI) in Kansas City, Mo.
NBTY, Inc., and its subsidiaries (collectively "NBTY"), a leading global manufacturer and distributor of high-quality vitamins and nutritional supplements, has been awarded the Healthy and Fit Workplace Award in honor of the array of wellness initiatives it has in place for its Associates. The company was formally recognized at a ceremony on November 7.
Access to some antiretroviral drugs is increasing in Thailand because of the country's decision to issue compulsory licenses for certain medications, Winai Sawasdiworn, deputy secretary-general of the National Health Security Office, said recently, the Bangkok Post reports (Apiradee, Bangkok Post, 5/8).
Arena Pharmaceuticals, Inc. announced today the initiation of patient screening in a Phase 1 clinical trial of APD916, a novel oral drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy and cataplexy.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144276114 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | (* (Not Available)) | Primary |
| Provider Name | Kenneth R Lander |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1154318988 PECOS PAC ID: 6305808312 Enrollment ID: I20041103000149 |
News Archive
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.
Adults who use pet therapy while recovering from total joint-replacement surgery require 50 percent less pain medication than those who do not. These findings were presented at the 18th Annual Conference of the International Society of Anthrozoology and the First Human Animal Interaction Conference (HAI) in Kansas City, Mo.
NBTY, Inc., and its subsidiaries (collectively "NBTY"), a leading global manufacturer and distributor of high-quality vitamins and nutritional supplements, has been awarded the Healthy and Fit Workplace Award in honor of the array of wellness initiatives it has in place for its Associates. The company was formally recognized at a ceremony on November 7.
Access to some antiretroviral drugs is increasing in Thailand because of the country's decision to issue compulsory licenses for certain medications, Winai Sawasdiworn, deputy secretary-general of the National Health Security Office, said recently, the Bangkok Post reports (Apiradee, Bangkok Post, 5/8).
Arena Pharmaceuticals, Inc. announced today the initiation of patient screening in a Phase 1 clinical trial of APD916, a novel oral drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy and cataplexy.
› Verified 1 days ago
| Provider Name | Erin M Mannella |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215250758 PECOS PAC ID: 6103954334 Enrollment ID: I20100510000509 |
News Archive
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.
Adults who use pet therapy while recovering from total joint-replacement surgery require 50 percent less pain medication than those who do not. These findings were presented at the 18th Annual Conference of the International Society of Anthrozoology and the First Human Animal Interaction Conference (HAI) in Kansas City, Mo.
NBTY, Inc., and its subsidiaries (collectively "NBTY"), a leading global manufacturer and distributor of high-quality vitamins and nutritional supplements, has been awarded the Healthy and Fit Workplace Award in honor of the array of wellness initiatives it has in place for its Associates. The company was formally recognized at a ceremony on November 7.
Access to some antiretroviral drugs is increasing in Thailand because of the country's decision to issue compulsory licenses for certain medications, Winai Sawasdiworn, deputy secretary-general of the National Health Security Office, said recently, the Bangkok Post reports (Apiradee, Bangkok Post, 5/8).
Arena Pharmaceuticals, Inc. announced today the initiation of patient screening in a Phase 1 clinical trial of APD916, a novel oral drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy and cataplexy.
› Verified 1 days ago
News Archive
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.
Adults who use pet therapy while recovering from total joint-replacement surgery require 50 percent less pain medication than those who do not. These findings were presented at the 18th Annual Conference of the International Society of Anthrozoology and the First Human Animal Interaction Conference (HAI) in Kansas City, Mo.
NBTY, Inc., and its subsidiaries (collectively "NBTY"), a leading global manufacturer and distributor of high-quality vitamins and nutritional supplements, has been awarded the Healthy and Fit Workplace Award in honor of the array of wellness initiatives it has in place for its Associates. The company was formally recognized at a ceremony on November 7.
Access to some antiretroviral drugs is increasing in Thailand because of the country's decision to issue compulsory licenses for certain medications, Winai Sawasdiworn, deputy secretary-general of the National Health Security Office, said recently, the Bangkok Post reports (Apiradee, Bangkok Post, 5/8).
Arena Pharmaceuticals, Inc. announced today the initiation of patient screening in a Phase 1 clinical trial of APD916, a novel oral drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy and cataplexy.
› Verified 1 days ago
Crozer-chester Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2600 W 9th St, Chester, PA 19013 Phone: 610-447-2000 Fax: 610-447-6620 | |
Crozer Chester Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Blvd, Acp 332, Chester, PA 19013 Phone: 610-447-7612 Fax: 610-447-7615 | |
Health Access Network Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Blvd, Pob Ii Suite 424, Chester, PA 19013 Phone: 610-338-1820 Fax: 610-388-1825 | |
Crozer Gastroenterology Associates Upland Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Blvd, Acp Suite 231, Chester, PA 19013 Phone: 610-619-7475 Fax: 610-619-7477 | |
Crozer Chester Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Blvd, Acp 332, Chester, PA 19013 Phone: 610-447-7612 Fax: 610-447-7615 | |
Crozer-chester Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2600 W 9th Street, Chester, PA 19013 Phone: 610-447-2000 Fax: 610-447-6620 |